GleamWall
中文EN

XFOR X4 Pharmaceuticals, Inc

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1501697 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY73.7%
TTM net income YoY15.3%
TTM EPS YoY106.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin68.8%
Operating margin-812.0%
Net margin-813.3%
FCF margin—
EBITDA margin-794.1%

Returns

ROE-80.3%
ROA-40.7%
ROIC (approx.)-134.7%
Asset turnover0.05x

Leverage & solvency

Liabilities / assets40.1%
Debt / equity0.54x
Current ratio13.22x
Interest coverage-9.26x

Cash quality & payout

Operating cash flow / net income0.95x
Accruals ratio-2.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$6.50M$2.60M
Cost of revenue$5.76M$797,000
Gross profit$743,000$1.80M
R&D expense$72.72M$81.64M
SG&A expense$43.52M$61.52M
Operating income-$86.88M-$36.40M
Interest expense$8.88M$8.77M
Pretax income-$79.16M-$37.14M
Income tax$41,000$310,000
Net income-$79.20M-$37.45M
EBITDA-$85.61M-$35.60M
EPS (basic)-1.87-5.59
EPS (diluted)-1.87-5.59
Weighted avg. shares (diluted)42.29M6.70M
Balance sheet
Cash & equivalents$217.05M$56.48M
Receivables$573,000$1.07M
Inventory$4.48M$2.82M
Current assets$261.58M$112.17M
PP&E, net$182,000$776,000
Goodwill$17.35M$17.35M
Intangibles$9.25M$10.00M
Total assets$290.46M$146.45M
Current liabilities$25.76M$32.88M
Long-term debt$75.00M$75.00M
Total debt$75.00M$75.00M
Total liabilities$104.17M$124.30M
Shareholders' equity$186.29M$22.15M
Net debt-$142.05M$18.52M
Shares outstanding90.91M5.70M
Cash flow statement
Operating cash flow-$85.62M-$130.90M
Capital expenditure$0$326,000
Free cash flow-$85.62M-$131.23M
Investing cash flow$8.15M$66.99M
Financing cash flow$238.63M$20.29M
Depreciation & amortization$1.28M$796,000
Stock-based compensation$4.30M$8.20M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.